White & Case and Wilson Sonsini Goodrich & Rosati advised Azurity Pharmaceuticals, Inc., and Kirkland & Ellis advised Slayback Pharma LLC on the transaction. Azurity Pharmaceuticals,...
Azurity Pharmaceuticals’ Acquisition of Slayback Pharma
Intra-Cellular Therapies’ $460 Million Shares Offering
White & Case has advised J.P. Morgan Securities LLC, SVB Leerink LLC, BofA Securities, Inc., Evercore Group L.L.C. and RBC Capital Markets, LLC as representatives of...
Gambling.com’s $42 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering, while White & Case LLP advised Gambling.com. Gambling.com Group Limited, a performance marketing company and a...
Entrada Therapeutics’ $116 Million Series B Financing
White & Case LLP advised Qatar Investment Authority on the deal. Qatar Investment Authority (QIA), the sovereign wealth fund of the State of Qatar, participated in a US$116...
CM Life Sciences II’s Business Combination with SomaLogic
White & Case LLP advised CM Life Sciences II, while Reed Smith advised SomaLogic on the deal. CM Life Sciences II, a special purpose acquisition company...